CS logo
small CS logo
Royal Alexandra Hospital

Edmonton, Alberta, Canada
Hospital in Edmonton, Alberta
10240 Kingsway NW, Edmonton, AB T5H 3V9
869 Beds

About Royal Alexandra Hospital


The Royal Alexandra Hospital is a large and long serving hospital in the Canadian province of Alberta. Operated by Alberta Health Services and located north of Edmonton's downtown core, the Royal Alexandra serves a diverse community stretching from Downtown Edmonton to western and northern Canada.
There are 869 beds in Royal Alexandra Hospital.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
University of Alberta
47
University of Calgary
7
University of British Columbia
6
Abbott Medical Devices
4
Boehringer Ingelheim
4
McMaster University
4
Daren K. Heyland
3
Ottawa Hospital Research Institute
3
Population Health Research Institute
3
Royal Alexandra Hospital
3
Unity Health Toronto
3
Total Rows: 72

Clinical Trials at Royal Alexandra Hospital


During the past decade, Royal Alexandra Hospital conducted 84 clinical trials. In the 10-year time frame, 84 clinical trials started and 24 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 8 clinical trials were completed. i.e. 36.4% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years19194416161515881111446611222255443311332222Started TrialsCompleted Trails20152016201720182019202020212022202301020
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Inhaled Nitric Oxide Study for Respiratory Failure in Newborns
1995-10-01
1998-05-01
Terminated
235
ARISE - Aggressive Reduction of Inflammation Stops Events
2003-06-01
2006-12-01
Unknown status
6,000
Study of Oral PG-116800 Following a Heart Attack
2003-09-01
2004-12-01
Completed
253
An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease
2002-09-01
2005-01-01
Completed
364
Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome
2004-05-25
2007-07-06
Completed
84
A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack
2005-05-01
2007-01-01
Terminated
658
Niacin Plus Statin to Prevent Vascular Events
2005-09-01
2012-12-01
Terminated
3,414
Which Therapy for Acute Heart Attacks? (The WEST Study)
2003-07-01
Completed
300

Rows per page:

1–100 of 160

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Royal Alexandra Hospital" #1 sponsor was "University of Alberta" with 47 trials, followed by "University of Calgary" with 7 trials sponsored, "University of British Columbia" with 6 trials sponsored, "Abbott Medical Devices" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 87 different institutions and companies that sponsored additional 72 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Alexandra Hospital" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 24 trials as a collaborator, "Alberta Health services" with 7 trials as a collaborator, "Alberta Innovates Health Solutions" with 5 trials as a collaborator, "Royal Alexandra Hospital" with 5 trials as a collaborator and "Canadian Critical Care Trials Group" with 4 trials as a collaborator. Other collaborators include 140 different institutions and companies that were collaborators in the rest 125 trials.
Created with Highcharts 11.1.0Top Leading SponsorsUniversity of Alberta: 47University of Alberta: 47University of Calgary: 7University of Calgary: 7University of British Columbia: 6University of British Columbia: 6Abbott Medical Devices: 4Abbott Medical Devices: 4Boehringer Ingelheim: 4Boehringer Ingelheim: 4McMaster University: 4McMaster University: 4Daren K. Heyland: 3Daren K. Heyland: 3Ottawa HospitalResearch Institute: 3Ottawa HospitalResearch Institute: 3Population HealthResearch Institute: 3Population HealthResearch Institute: 3Royal Alexandra Hospital: 3Royal Alexandra Hospital: 3

Created with Highcharts 11.1.0Top CollaboratorsCanadian Institutes ofHealth Research (CIHR):24Canadian Institutes ofHealth Research (CIHR):24Alberta Health services: 7Alberta Health services: 7Alberta InnovatesHealth Solutions: 5Alberta InnovatesHealth Solutions: 5Royal Alexandra Hospital: 5Royal Alexandra Hospital: 5Canadian Critical CareTrials Group: 4Canadian Critical CareTrials Group: 4Eli Lilly and Company: 4Eli Lilly and Company: 4Medtronic: 4Medtronic: 4University of Alberta: 4University of Alberta: 4Baxter HealthcareCorporation: 3Baxter HealthcareCorporation: 3University of Toronto: 3University of Toronto: 3

Clinical Trials Conditions at Royal Alexandra Hospital


According to Clinical.Site data, the most researched conditions in "Royal Alexandra Hospital" are "Heart Failure" (12 trials), "Critical Illness" (9 trials), "Myocardial Infarction" (9 trials), "Atrial Fibrillation" (6 trials) and "Coronary Artery Disease" (4 trials). Many other conditions were trialed in "Royal Alexandra Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Royal Alexandra Hospital


Most popular intervention types in "Royal Alexandra Hospital" are "Drug" (56 trials), "Device" (34 trials), "Procedure" (34 trials), "Other" (24 trials) and "Behavioral" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (17 trials), "Empagliflozin" (3 trials), "placebo" (3 trials), "Anti-Arrhythmic Drug Therapy" (2 trials) and "CC+SI" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Royal Alexandra Hospital


The vast majority of trials in "Royal Alexandra Hospital" are 151 trials for "All" genders and 9 trials for "Female" genders.

Clinical Trials Status at Royal Alexandra Hospital


Currently, there are 33 active trials in "Royal Alexandra Hospital". 1 are not yet recruiting, 21 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 88 completed trials in Royal Alexandra Hospital, undefined suspended trials, and 21 terminated clinical trials to date.
Out of the total trials that were conducted in Royal Alexandra Hospital, 1 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 57 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhaseNot Applicable: 57Not Applicable: 57Phase 3: 54Phase 3: 54Phase 2: 19Phase 2: 19Phase 4: 11Phase 4: 11Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 88Completed: 88Recruiting: 21Recruiting: 21Terminated: 21Terminated: 21Unknown status: 13Unknown status: 13Active, not recruiting: 10Active, not recruiting: 10Withdrawn: 5Withdrawn: 5Enrolling by invitation: 1Enrolling by invitation: 1Not yet recruiting: 1Not yet recruiting: 1